Requirement for Ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells
Pl. Woo et al., Requirement for Ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells, J BIOL CHEM, 274(46), 1999, pp. 32818-32828
In Con8 rat mammary epithelial tumor cells, the synthetic glucocorticoid de
xamethasone stimulates the remodeling of the apical junction (tight and adh
erens junctions) and the transepithelial electrical resistance (TER), which
reflects tight junction sealing. Indirect immunofluorescence revealed that
dexamethasone induced the recruitment of endogenous Ras and the p85 regula
tory subunit of phosphatidylinositol (PI) I-kinase to regions of cell-cell
contact, concurrently with the stimulation of TER. Expression of dominant-n
egative RasN17 abolished the dexamethasone stimulation in TER, whereas, dex
amethasone induced the reorganization of tight junction and adherens juncti
on proteins, ZO-1 and beta-catenin, as well as F-actin, to precise regions
of cell-cell contact in a Res-independent manner. Confocal microscopy revea
led that RasN17 and the p85 regulatory subunit of PI 3-kinase co-localized
with ZO-1 and F-actin at the tight junction and adherens junction, respecti
vely. Treatment with either of the PI S-kinase inhibitors, wortmannin or LY
294002, or the MEK inhibitor PD 098059, which prevents MAPK signaling, atte
nuated the dexamethasone stimulation of TER without affecting apical juncti
on remodeling. Similar to dominant-negative RasN17, disruption of both Ras
effector pathways using a combination of inhibitors abolished the glucocort
icoid stimulation of TER. Thus, the glucocorticoiddependent remodeling of t
he apical junction and tight junction sealing can be uncoupled by their dep
endence on Ras and/or PI S-kinase-dependent pathways, implicating a new rol
e for Ras and PI 3-kinase cell signaling events in the steroid control of c
ell-cell interactions.